Tulane StARR Program
Tulane StARR Program
批准号:
10318191
负责人:
JAY K KOLLS
金额:
$30.8万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-01 至 2024-12-31
关键词:
AchievementAddressAmericanAreaBasic ScienceCenters of Research ExcellenceChildhoodClinicClinicalClinical MedicineClinical ResearchClinical SciencesClinical TrialsCommunicationDevelopmentDevelopment PlansDiagnosisDiseaseDiverse WorkforceEducational workshopEligibility DeterminationEngineeringEnsureEnvironmentEvaluationExposure toFacultyFellowshipFosteringFundingGoalsGrantHealthHeart DiseasesHematological DiseaseHumanIndividualInstitutional support resourcesInterdisciplinary StudyInternal MedicineKnowledgeLaboratoriesLaboratory ResearchLeadLeadershipLearningLongevityLung diseasesMedicalMedicineMentorsMinorityModelingMolecular GeneticsMonitorNational Heart, Lung, and Blood InstitutePediatricsPhysiciansPopulationPopulation ResearchPositioning AttributePrevention ResearchPrimatesPrincipal InvestigatorProductivityProgram DevelopmentProgram EffectivenessPublic HealthResearchResearch MethodologyResearch Project GrantsResearch SupportResearch TrainingResidenciesResourcesRotationSECTM1 geneScholarshipScienceScientistSelf EfficacySeriesStructureStudentsTeacher Professional DevelopmentTimeTrainingTraining ProgramsTraining SupportTranslatingTranslational ResearchTropical MedicineUnited States National Institutes of HealthUniversitiesWagesWomanWood materialWritingbasecareercareer developmentclinical carecollaborative environmentdesignefficacy evaluationefficacy researchepidemiology studyhealth science researchhuman diseaseimplementation researchimprovedindividual patientinnovationinterestmedical schoolsmedical specialtiesmeetingsnext generationnovel strategiespatient orientedpopulation healthprogramsrecruitresearch and developmentskillssuccesstime use
中文摘要
计划摘要
这是杜兰斯塔尔计划的一项新申请,长期目标是增加人数和
从事心脏研究的训练有素的、独立的、跨学科的委员会认证的医生科学家的多样性,
肺病、血液病的研究。该项目专注于心脏、肺和血液疾病,因为
这些疾病对人类健康的影响,以及世界各国对这些疾病存在的认识差距。
搜索范围,以及杜兰大学这些重点领域的实力。我们成功男人的关键要素-
经过培训的研究和职业发展STARR计划包括:1)训练营和教学
特殊学者需求;2)个性化职业发展培训;3)斯塔尔内科科学家研讨会
系列;4)正在进行的会议;5)要求编写赠款和项目管理讲习班;6)男子--
注重跨学科研究;7)研究培训中负责任的行为;8)机构资源;9)a)
斯塔尔学者计划过渡到奖学金培训、K38、K12、类似K的计划,以及生物中心-
卓越医学研究奖(Cobre)。创新的方法包括为学者项目量身定做
需要使用自我效能评估和个人发展计划(IDP),并使用网络指导
每个学者监督委员会(SOC)的模式,其中将包括基础和临床科学方面的专业知识-
以及相关住院医师计划主任的参与,以确保适当的-
临床和研究轮换的ATE整合。学者们立即接触到研究,并得到指导
及早建立学术记录,并通过积极参与获得演讲和组织技能
在健康科学研究日、国家科学会议和NIH STARR年度会议上。这个
学者们将从BASCH(细胞、分子和遗传学)学习尖端研究方法和技能,以
从床边(临床研究和临床试验)到人群(流行病学、预防和实施
研究),并在现有的实验室/研究小组中开展自己的研究项目,由32个
NIH资助的教官在一个有指导的、跨学科的环境中站立起来,解决NHLBI的优先事项。
学者们的跨学科研究将集中在心肺和血液疾病上,并解决总体问题
主题(寿命和跨学科研究)。在杜兰大学的大力机构支持下,
由美国内科委员会和美国儿科委员会提供的培训,我们建议
6名常驻斯塔尔学者(3名医学住院医生和3名儿科住院医生;50%为女性,25%为URM),为期18年
几个月(在PGY 2、PGY3和PGY4的6个月研究区块中,80%的精力致力于研究)
为期4年的实习计划,同时保持诊所的连续性。持续和全面的评估将
评估和指导STARR计划在以下方面的有效性改进:1)衔接研究、培训和再培训
搜索独立性;2)确保内科和儿科住院医生的董事会资格;以及3)增加
内科科学家的数量和多样性将科学转化为在整个生命周期内改善人类健康。
英文摘要
Program Summary
This is a new application for the Tulane StARR Program with a long-term goal to increase the number and
diversity of highly trained, independent, interdisciplinary board-certified physician scientists engaging in heart,
lung, and blood diseases research. The program focuses on heart, lung, and blood diseases because of the
impacts of these diseases on human health, the existing knowledge gaps for these diseases across the re-
search spectrum, and the strength of these areas of focus at Tulane. Key components of our successful men-
tored research and career development StARR program include: 1) Boot Camps and didactics tailored to
specific Scholar needs; 2) individualized career development training; 3) StARR Physician Scientists seminar
series; 4) Work-in-Progress sessions; 5) required grant writing and project management workshops; 6) men-
tored interdisciplinary research; 7) responsible conduct in research training; 8) institutional resources; and 9) a
planned transition for StARR Scholars to fellowship training, K38, K12, K-like programs, and Centers of Bio-
medical Research Excellence (COBRE). The innovative approach involves tailoring the program to Scholars
needs using self-efficacy assessment and individual development plans (IDP), and using a network mentoring
model for each Scholar Oversight Committee (SOC) which will include expertise in both basic and clinical sci-
ence and clinical care, as well as participation by the relevant Residency Program Director to ensure appropri-
ate integration of clinical and research rotations. Scholars are immediately exposed to research and are guided
to establish a scholarly track record early, and gain presentation and organization skills by active participation
in the Health Sciences Research days, national scientific meetings, and the annual NIH StARR meeting. The
Scholars will learn cutting-edge research methods and skills from Bench (cellular, molecular, and genetics), to
Bedside (clinical research and clinical trials) to Population (epidemiology, prevention, and implementation
research) and conduct their own research projects in established laboratories/research groups led by 32 out-
standing NIH-funded preceptors in a mentored, interdisciplinary environment that addresses NHLBI priorities.
Scholars' interdisciplinary research will focus on heart, lung, and blood diseases and address overarching
themes (lifespan and interdisciplinary research). With strong institutional support from Tulane and approval of
the training by the American Board of Internal Medicine and American Board of Pediatrics, we propose to train
6 resident StARR Scholars (3 medicine residents and 3 pediatric residents; 50% women and 25% URM) for 18
months (in 6-month Research Blocks in PGY 2, PGY3, and PGY4 with 80% effort dedicated to research) over
the 4-year residency program while maintaining Continuity Clinics. Ongoing and comprehensive evaluation will
assess and guide improvements to the StARR Program's effectiveness in 1) bridging research training and re-
search independence; 2) ensuring board eligibility for medicine and pediatrics residents; and 3) increasing the
number and diversity of physician scientists translating science to improve human health across the lifespan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Tulane StARR Program
-
批准号:10608042
-
项目类别:
-
资助金额:$30.8万
-
财政年份:2021
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:9981924
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:10443796
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:10227140
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
Immunotherapy of KPC Infection
-
批准号:10671653
-
项目类别:
-
资助金额:$48.64万
-
财政年份:2020
-
负责人:JAY K KOLLS
-
依托单位:
CD4_T-cell_Immunity_in_the_Lung
-
批准号:10321572
-
项目类别:
-
资助金额:$86.92万
-
财政年份:2018
-
负责人:JAY K KOLLS
-
依托单位:
CD4_T-cell_Immunity_in_the_Lung
-
批准号:10559497
-
项目类别:
-
资助金额:$86.92万
-
财政年份:2018
-
负责人:JAY K KOLLS
-
依托单位:
Training in CD4 T-cell Lung Immunity
-
批准号:9804524
-
项目类别:
-
资助金额:$9.37万
-
财政年份:2018
-
负责人:JAY K KOLLS
-
依托单位:
Generation of Novel Human Monoclonals for Lung Disease
-
批准号:9250044
-
项目类别:
-
资助金额:$6.79万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Generation of Novel Human Monoclonals for Lung Disease
-
批准号:9128312
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
-
批准号:10521311
-
项目类别:
-
资助金额:$47.95万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
-
批准号:10375091
-
项目类别:
-
资助金额:$51.07万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Improved Therapeutics and Diagnostics for Pneumocystis Pneumonia
-
批准号:9210593
-
项目类别:
-
资助金额:$24.87万
-
财政年份:2016
-
负责人:JAY K KOLLS
-
依托单位:
Th17 Cytokines and Lung Immunity
-
批准号:8990110
-
项目类别:
-
资助金额:$8.62万
-
财政年份:2015
-
负责人:JAY K KOLLS
-
依托单位:
Th17 Cytokines and Lung Immunity
-
批准号:9193101
-
项目类别:
-
资助金额:$26.39万
-
财政年份:2015
-
负责人:JAY K KOLLS
-
依托单位:
Core C RNA Sequencing and Bioinformatics
-
批准号:8853015
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2015
-
负责人:JAY K KOLLS
-
依托单位:
UPITT Rheumatoid Arthritis Combined Center (UPITT RACC)
-
批准号:8932653
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2014
-
负责人:JAY K KOLLS
-
依托单位:
Novel Macrolide Th17 Inhibitors
-
批准号:8130158
-
项目类别:
-
资助金额:$7.89万
-
财政年份:2011
-
负责人:JAY K KOLLS
-
依托单位:
Novel Macrolide Th17 Inhibitors
-
批准号:8255486
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2011
-
负责人:JAY K KOLLS
-
依托单位:
Novel Macrolide Th17 Inhibitors
-
批准号:8389005
-
项目类别:
-
资助金额:$10.49万
-
财政年份:2011
-
负责人:JAY K KOLLS
-
依托单位:
海外基金